BioSpace News Archive

Akcea Therapeutics, Inc., an affiliate of Ionis Pharmaceuticals, Inc., announced that it will host a live webcast on Tuesday, November 5th at 4:30 p.m. Eastern Time to discuss its third quarter 2019 financial results and report on pipeline and business progress..

Anixa Biosciences, Inc. announced the acceptance of an abstract at the 34th Annual Meeting of the Society for Immunotherapy of Cancer A poster presentation will include data from ongoing studies utilizing Cchek™, the company’s artificial intelligence driven cancer detection technology.

First Pivotal Study to Investigate Permanent Vascular Implant as a Treatment for Post-Angioplasty Dissections in Arteries Below the Knee (BTK)

Rocket’s Largest Lentiviral Pipeline Opportunity with an Estimated Prevalence of 3,000 to 8,000 Patients in the U.S. and EU

VIVUS, Inc. (Nasdaq: VVUS) today announced that it will report financial results and provide a business update for the third quarter of 2019 after the market close on Tuesday, November 5, 2019.

IntelGenx Corp., a leader in pharmaceutical films, announced that its 505 New Drug Application for RIZAPORT® VersaFilm® for the treatment of acute migraines has been accepted for review by the U.S. Food and Drug Administration

Diverse insights provided by expert Board members to accelerate company direction

Berkeley-headquartered startup secures an oversubscribed round led by NFX; additional investors in the round include Precursor Ventures, Sound Ventures (founded by Ashton Kutcher and Guy Oseary), FJ Labs and Friále (founded by Bryan Frist of HCA Healthcare’s founding family)

Data presented today at CHEST 2019 Annual Meeting; Company plans to begin making test available in early 2021

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it plans to release third quarter 2019 financial and operating results, and certain guidance for the fourth quarter and full year 2019, prior to market open on Tuesday, November 5, 2019